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ABSTRACT Since its introduction to Ca2 signaling
in 1997, 2-aminoethoxydiphenyl borate (2-APB) has
been used in many studies to probe for the involvement
of inositol 1,4,5-trisphosphate receptors in the genera-
tion of Ca2 signals. Due to reports of some nonspe-
cific actions of 2-APB, and the fact that its principal
antagonistic effect is on Ca2 entry rather than Ca2
release, this compound may not have the utility first
suggested. However, 2-APB has thrown up some inter-
esting results, particularly with respect to store-oper-
ated Ca2 entry in nonexcitable cells. These data
indicate that although it must be used with caution,
2-APB can be useful in probing certain aspects of Ca2
signaling.—Bootman, M. D., Collins, T. J., Mackenzie,
L., Roderick, H. L., Berridge, M. J., Peppiatt, C. M.
2-Aminoethoxydiphenyl borate (2-APB) is a reliable
blocker of store-operated Ca2 entry but an inconsis-
tent inhibitor of InsP3-induced Ca
2 release. FASEB J.
16, 1145–1150 (2002)
Of the multiple presently recognized mechanisms of
mobilizing intracellular Ca2 stores (1), the pathway
involving release of Ca2 by inositol 1,4,5-trisphosphate
(InsP3) has possibly the least useful membrane-per-
meant pharmacology. Ryanodine receptors in intact
cells, for example, can be rapidly activated by caffeine
and specifically inhibited in a use-dependent manner
by ryanodine (for reviews, see refs 2, 3). InsP3 receptors
(InsP3Rs) can be specifically activated using a mem-
brane-permeant InsP3 ester (4; for example, see ref 5),
but the choice of antagonists of InsP3 action is limited.
One of the most commonly used InsP3R antagonists is
heparin. This compound is limited because it has
multiple actions, including uncoupling G-protein sig-
naling and activating ryanodine receptors (for reviews,
see refs 2, 6). Furthermore, heparin has to be either
injected or infused into cells, although it has been
suggested that low molecular weight heparin species
may cross the plasma membrane and thus inhibit
InsP3Rs within intact cells (7). Xestospongins, which
were first described as specific membrane-permeant
InsP3R antagonists by Pessah and colleagues (8), have
been used many times to prove whether InsP3Rs are
involved in particular responses. Although there are
many examples of xestospongin inhibiting Ca2 signal-
ing, its mechanism of action has not been fully eluci-
dated. Xestospongin is expensive, often slow to act, and
has not been successful in all labs. It was against this
backdrop of a shortage of rapidly working, low-cost
membrane-permeant antagonists of phosphoinositide
signaling that 2-APB appeared to have great potential.
Although there are numerous examples of 2-APB
inhibiting Ca2 signaling in intact cells, its mechanism
of action is unclear. In addition to attenuating the
release of internal Ca2 stores, 2-APB can also inhibit
the store-operated channels (SOCs) that replenish the
Ca2 pool, suggesting that the inhibition of SOC may
be a primary target for 2-APB.
SPECIFIC ACTIONS OF 2-APB ON Ca2
RELEASE BY InsP3 RECEPTORS
The initial report by Mikoshiba and colleagues demon-
strated that 2-APB gave a concentration-dependent
inhibition of InsP3-induced Ca
2 release from mouse
cerebellar membranes without affecting InsP3 binding
(9). It did not modulate InsP3 production in platelets
nor did it affect Ca2 release from striated muscle
vesicles activated by modest concentrations of caffeine,
signifying that it did not interact with ryanodine recep-
tors. Smooth muscle cell contraction in response to an
InsP3-generating stimulus was inhibited by 2-APB,
whereas that triggered by KCl-induced depolarization
was unaffected, suggesting there was an effect on
neither voltage-operated Ca2 entry nor the contractile
machinery. 2-APB appeared to be rapidly cell per-
meant. Most of the claims made in the study by
Maruyama et al. (9) have been substantiated by later
studies, although 2-APB does not appear to be equally
potent at inhibiting InsP3-induced Ca
2 release in all
cell types.
Ironically, the inhibitory effect of 2-APB on Ca2
release via InsP3Rs is perhaps the most controversial of
its actions. The cell types where 2-APB has been shown
to have effects consistent with inhibition of InsP3-
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induced Ca2 release include platelets (9, 10), supra-
chiasmatic nucleus (11), ventricular cardiomyocytes
(12), various types of smooth muscle (9, 13–18), toad
sinus venosus (19), pancreatic  cells (20), fungal
growth tips (21), hippocampal neurons (22), skeletal
myotubes (23), neutrophils (24), and endothelial cells
(25). Generally, these studies found that over the range
1–100 M, 2-APB inhibited Ca2 signals due to the
release of intracellular stores and subsequent Ca2
entry. However, in many of these studies, 2-APB has
been used to demonstrate the involvement of InsP3Rs
without consideration of additional effects.
Results obtained using permeabilized cells, cell mem-
branes, and intact cells suggest that 2-APB may not be a
consistent blocker of InsP3Rs. Whereas Maruyama et al.
(9) and others (e.g., refs 26, 27) found that InsP3-
induced Ca2 release in permeabilized cells was inhib-
ited in a concentration-dependent manner by 2-APB,
different studies have reported either weak inhibition
or no effect on InsP3-induced Ca
2 release (e.g., 28).
Why 2-APB has such a variable effect on InsP3-
induced Ca2 release in intact or permeabilized cells is
unclear. One possibility, suggested by Kukkonen et al.
(29), is that 2-APB shows selectivity for different InsP3R
isoforms. Consistent with this notion, some of the most
prominent effects of 2-APB have been seen in cell types
that largely express types 1 and 3 InsP3Rs, whereas cells
that express largely type 2 InsP3Rs seem to be insensi-
tive. However, there are exceptions to this rule, which
suggests it is perhaps only a partial explanation. An
alternative possibility derives from the mixed mode of
inhibition of InsP3-induced Ca
2 release by 2-APB. The
inhibitory effect of 2-APB can be partially out-competed
by increasing InsP3 concentration. The IC50 for inhibi-
tion of InsP3-evoked Ca
2 release is therefore depen-
dent on the ambient InsP3 concentration. In experi-
ments by Maruyama et al. (9), Ca2 released from
cerebellar membranes by 100 nM InsP3 was inhibited
by 2-APB with an IC50 of 10–20 M. The maximal
response of cerebellar microsomes to InsP3 is achieved
with 10 M InsP3; at this concentration of InsP3, the
IC50 for 2-APB is 1 mM (J. Bilmen and F. Michelan-
geli, personal communication). The discrepant effects
of 2-APB in blocking agonist-induced Ca2 release in
intact cells may therefore indicate that different cell
types generate substantially varying levels of InsP3.
However, this is also likely to be only a partial explana-
tion, since the same concentrations of 2-APB and InsP3
have been shown to have contrasting effects in different
cell types (e.g., compare refs 27, 28). Although there is
no apparent resolution to the divergent effects of
2-APB on InsP3-induced Ca
2 release in different stud-
ies, these data do highlight the need for caution in
simply using 2-APB as an InsP3R antagonist. In some
situations, 2-APB attenuates Ca2 signaling without
modulating Ca2 flux through InsP3Rs. In these cases,
the action of 2-APB can be explained by inhibition of
Ca2 entry.
SPECIFIC ACTIONS OF 2-APB ON Ca2 ENTRY
THROUGH SOCs
Even though the data presented by Maruyama et al. (9)
made a reasonable case for 2-APB acting as a specific
membrane-permeable InsP3R antagonist, emerging
data show that its primary action on cells is not to block
Ca2 release, but rather to inhibit SOC influx. The
study that really brought 2-APB into the limelight—
demonstrating the involvement of InsP3Rs in coupling
to SOC channels (30)—must be interpreted in the light
that 2-APB can inhibit SOC directly without involve-
ment of InsP3Rs (27, 28, 31–34).
Despite its widespread use, there is presently no
clear-cut evidence for 2-APB inhibiting Ca2 signaling
by solely targeting InsP3Rs. At best, it seems that in
some cells 2-APB can inhibit both agonist-induced Ca2
release and the concomitant SOC with the same effi-
cacy (e.g., refs 16, 27). In contrast, there are several
studies of intact cells where 2-APB was found not to
inhibit InsP3-induced Ca
2 release, but it could still
block Ca2 entry. For example, Barritt and colleagues
(28) found that concentrations of 2-APB of up to 100
M had no effect on Ca2 release during vasopressin
stimulation of primary hepatocytes, but it did cause a
concentration-dependent inhibition of Ca2 influx
with an IC50 of 10 M. Thapsigargin-induced Ca
2
influx was inhibited with a comparable concentration
dependence. A similar effect of 2-APB inhibiting SOC
without affecting Ca2 release has been demonstrated
for CHO cells (29).
The best evidence for 2-APB inhibiting SOC through
a mechanism not involving InsP3Rs is that it is still
effective in cells that do not express InsP3Rs at all (27,
31, 34, 35). Activation of Drosophila photoreceptors
relies on the gating of light-activated cation channels in
the plasma membrane of these cells. It is well estab-
lished that the InsP3Rs expressed in Drosophila photo-
receptors are not necessary for vision, yet 2-APB still
blocked light-induced cation entry (27, 36).
2-APB does not inhibit SOC when internally perfused
within cells (31, 32) or applied to the cytosolic surface
of excised membrane patches (33). Extracellularly ap-
plied 2-APB inhibits SOC in platelets with no measur-
able delay, similar to inorganic ions such as lanthanum
(37). These data indicate that 2-APB blocks SOC by
interacting at the outside of cells. The manner in which
2-APB prevents SOC is unclear. The agonist-induced
activation of the putative SOC channel TRP3 heterolo-
gously expressed in HEK cells was inhibited by 2-APB
whereas activation of the same channel by diacylglyc-
erol analogs was not (30). Similarly, in Drosophila pho-
toreceptors, 2-APB blocked light-induced cation entry
but not that evoked by metabolic stress (36). If 2-APB
simply occluded these channels, it should prevent their
activation by any means. These data therefore suggest
that 2-APB probably does not bind directly to the
channels, but rather interacts upstream in their activa-
tion mechanism (see also ref 38).
If 2-APB is to be used as a SOC inhibitor, it is essential
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that it has good selectivity for those channels. The
original study demonstrated that it had no effect on
voltage-operated Ca2 channels (9), a finding sup-
ported by several other studies (11, 13, 16, 19, 23).
Several other non-voltage-activated Ca2 entry path-
ways that are distinct from SOC are not inhibited by
2-APB, including S-nitrosylation-induced influx in a
smooth muscle cell line (39), maitotoxin-evoked Ca2
entry in hepatocytes (28), Ca2 influx caused by diac-
ylglycerol analogs in PC12 cells (40), muscarinic activa-
tion of nonselective cation channels in smooth muscle
(41), and arachidonate-stimulated Ca2 channels in
HEK293 cells (38) and HeLa cells (authors’ unpub-
lished observations).
Despite its lack of action on the non-SOC Ca2 entry
pathways listed above, 2-APB is not completely specific
for SOC channels, as it has been shown to inhibit
MagNuM channels (also known as LTRPC7 and TRP-
PLIK; ref 42). MagNuM is a widely expressed ion
channel that conducts Ca2 and Mg2 at negative
membrane potentials. This channel is not regulated by
store depletion, but instead is activated by a decrease in
intracellular levels of magnesium nucleotides (43).
Although SOC and MagNuM may be difficult to dis-
criminate if they are simultaneously switched on, since
the latter is not activated by store depletion it is likely
that the flux of Ca2 through this channel will not be
appreciably altered by mild treatments that activate
SOC. Under many experimental conditions, therefore,
it is likely that a block of Ca2 entry by 2-APB would
reflect and affect SOC channels rather than MagNuM.
In rat basophilic leukemia cells, the effect of 2-APB on
MagNuM was rapidly reversible whereas its effects on
SOC were not (42). The reversibility of 2-APB may
therefore provide a means of discriminating between
different targets.
2-APB also modifies the conductance through CaT1
channels (44). These channels were suggested to un-
derlie ICRAC, a well-characterized form of SOC (45).
However, whereas 2-APB irreversibly inhibits ICRAC, it
reversibly potentiates the conductance of CaT1 chan-
nels, suggesting they are not the same (44).
At present, the bulk of data supports the notion that
2-APB is an almost universal blocker of SOC and some
TRP isoforms (35) while being a rather variable inhib-
itor of InsP3-induced Ca
2 release. Whereas substan-
tially different concentrations of 2-APB are needed to
inhibit InsP3-induced Ca
2 release in different cell
types, SOC is generally fully inhibited by 50–100 M
2-APB. The present exceptions to this are SH-SY5Y cells,
which appear to be completely insensitive to 2-APB
(29), and neutrophils where Ca2 signals in response to
platelet-activating factor were totally blocked by 100 nM
2-APB (46).
POTENTIALLY UNHELPFUL ACTIONS OF 2-APB
In addition to its effects on InsP3-induced Ca
2 release
and SOC, 2-APB has been shown to enhance the
nonspecific leak of Ca2 from the intracellular Ca2
pool (26) and to inhibit the SERCA pumps respon-
sible for loading intracellular Ca2 stores (9, 26).
Consistent with the enhancement of a Ca2 leak, in
some intact cell studies 2-APB caused a rise in basal
Ca2 levels (9, 10, 12, 28). When applied to electri-
cally paced cardiac myocytes at concentrations  10
M, 2-APB caused a transient increase in the ampli-
tude of systolic Ca2 rises, followed by a progressive
diminution of the electrically evoked responses (au-
thors’ unpublished observations). This effect is con-
sistent with an inhibition of SERCA activity leading
initially to an enhanced response due to less Ca2
sequestration, but the lack of Ca2 store refilling
eventually leads to a failure of excitation-contraction
coupling.
2-APB prevents mitochondria from releasing Ca2
they have sequestered (31), possibly by an inhibitory
action on the sodium/Ca2 exchanger. We have found
that 2-APB at 100 M causes mitochondria to swell and
change shape, but without causing them to depolarize
(authors’ unpublished observations).
These actions of 2-APB may render it useless in some
situations. However, in experimental protocols investi-
gating SOC activity, the intracellular Ca2 pool is
often completely discharged by application of sub-
stances such as thapsigargin. Under those conditions,
any effect of 2-APB on the Ca2 leak or SERCAs
would be irrelevant. Although mitochondria and
intracellular Ca2 signaling systems communicate
bidirectionally, the effect of inhibiting mitochondrial
Ca2 release on a particular response can be directly
tested by using the sodium/Ca2 exchange blocker
GCP37157 (47).
Another potentially limiting feature of 2-APB is that
it is poorly reversible in some cell types. In toad sinus
venosus, for example, it took  1 h for the inhibitory
effects of 60 M 2-APB to be reversed (19, see also refs
27, 31, 32). These data contrast with other studies
where the inhibitory effects 2-APB were reversed within
a few minutes (28) or even immediately (36). In studies
of cardiac myocytes, we have found that the concentra-
tion of 2-APB applied to cells determined its reversibil-
ity. 2-APB inhibited spontaneous diastolic Ca2 tran-
sients evoked by endothelin 1. At concentrations of 5
M, this effect was readily reversible, whereas higher
concentrations gave a prolonged inhibition (unpub-
lished results).
Some of the discrepant effects of 2-APB may be due
to its ability to exist as different species. Besides the
open-chain monomeric form, it has been suggested to
dimerize (39) and form a monomeric heterocyclic
compound with an internal coordinate nitrogen-boron
bond (10). It was proposed that 2-APB dimers resemble
Xestospongins, indicating a common mechanism of
action (39), but this seems unlikely (10). A comparison
of structural analogs of 2-APB that inhibit Ca2 signal-
ing in platelets has suggested that the diphenyl moiety
is important for its activity (10).
The pKb of 2-APB is  10, which means that in
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physiological pH its amine group will be protonated,
giving the molecule a net positive charge (J. Bilmen
and F. Michelangeli, personal communication; ref 10).
We have found that 2-APB causes a rapid cytoplasmic
acidification that is slowly reversible, suggesting that it
either carries protons across the membrane or dis-
places them from internal sites (authors’ unpublished
observations).
SIMILARITY BETWEEN THE ACTIONS OF 2-APB
AND XESTOSPONGIN
The observations of multiple conflicting effects of
2-APB may also sound a note of caution for users of
Xestospongins. Ironically, Xestospongins have been
used in more studies than 2-APB, yet we probably know
more about the latter compound. In several studies, the
results of using 2-APB and Xestospongins have been the
same, and their common effect interpreted as clear
evidence for involvement of InsP3Rs (e.g., refs 25, 30).
However, since the interpretation of data obtained
using 2-APB has to be reevaluated in the light of its
action on SOC, so Xestospongin cannot simply be
regarded as an InsP3R antagonist. Indeed, Xestospon-
gin is capable of inhibiting SOC in DT40 cells where
InsP3Rs are absent (D. L. Gill, personal communica-
tion). Just like 2-APB, Xestospongin can inhibit
SERCAs (48) and cause release of Ca2 from stores in
intact cells (e.g., 49). There is a striking similarity
between Xestospongin and 2-APB in the range of
targets (SOC, InsP3Rs, SERCA) and in their rather
variable action on different cell types.
POTENTIATION OF Ca2 SIGNALING BY 2-APB
Although much of the data obtained using 2-APB have
suggested that it blocks Ca2 signaling in intact cells,
there are several reports of 2-APB enhancing Ca2
release and Ca2 entry. In rat basophilic leukemia cells
and Jurkat cells, ICRAC had a biphasic dependence on
2-APB concentration; it was potentiated by low micro-
molar concentrations of 2-APB and inhibited by higher
levels of 2-APB (31). This was independent of any
effects of 2-APB on InsP3Rs, since ICRAC in DT40 cells
not expressing InsP3Rs showed a similar biphasic de-
pendence on 2-APB concentration (31; but see ref 44).
A transient facilitation of the light-induced current by
2-APB was observed in Drosophila photoreceptors (36).
2-APB potentiated Ca2 signals in mouse pancreatic
cells during agonist stimulation or during internal
perfusion with InsP3 (50).
The enhanced leak of Ca2 from the endoplasmic
reticulum and inhibition of SERCA activity by 2-APB
may underlie some of the observed potentiation of
Ca2 signaling and the suggestion that 2-APB may act
as an agonist of InsP3Rs (51). Ca
2 that is nonspe-
cifically released by stores can positively stimulate
further InsP3 production or Ca
2 release (e.g., 52).
Removal of Ca2 sequestration by SERCA inhibition
will remove a negative feedback component from the
responses. Therefore, whereas potentiatory effects of
2-APB on Ca2 entry might reflect modulation of
channels (31), enhancement of Ca2 release proba-
bly reflects actions of 2-APB on the Ca2 leak and
SERCAs.
SUMMARY
2-APB has been rapidly adopted as an InsP3R antag-
onist by the Ca2 signaling community. However,
2-APB cannot simply be used as an InsP3R antagonist
in most situations, since it has multiple targets and
can potentiate some Ca2 responses. Inhibition of
InsP3-mediated Ca
2 release by 2-APB is extremely
variable between studies. An almost universal obser-
vation is that 2-APB inhibits SOC. However, this is not
via an effect on InsP3Rs, nor is it due to direct
blocking of the Ca2 entry channels. The multiple
actions of 2-APB are strikingly similar to those of
Xestospongin, implying that the data obtained with
both compounds must be interpreted cautiously.
Despite the many effects of 2-APB, it does have uses,
for example, in investigating the activation of SOC
and in discriminating between different forms of
Ca2 entry. Careful titration of 2-APB concentration
may allow inhibition of InsP3-induced Ca
2 release
and SOC without significant SERCA inhibition or
nonspecific Ca2 release. In many situations 2-APB
cannot be regarded as a marker for the involvement
of InsP3Rs in the generation of Ca
2 signals.
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